Concepedia

Author

Pan Suo

Peking University People's HospitalORCID

Also Known As

P Suo, Pan Suo, suo pan

30

Publications

349

Citations

9

H-Index

14

Concepts

All Affiliations

Peking University People's HospitalPeking UniversityChinese Academy of Medical Sciences & Peking Union Medical CollegeShenzhen Genoimmune Medical InstituteCenter for Life Sciences
PS

About

Pan Suo is an author at Peking University People's Hospital specializing in medicine, transplantation, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

150

2

Health Sciences

2

2

135

3

Cellular Therapies

2

2

135

4

Blood Transplantation

1

1

102

5

Cell Biology

1

1

102

Pan Suo

×

9

Publications

312

Citations

9

H-Index

YearCitations

Donor‐derived<scp>CD</scp>19‐targeted T cell infusion induces minimal residual disease‐negative remission in relapsed B‐cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation

Yu‐Hong Chen, Yifei Cheng, Pan Suo,

British Journal of Haematology

2017

102

Early myeloid-derived suppressor cells (HLA-DR−/lowCD33+CD16−) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT

Ke Wang, Meng Lv, Ying‐Jun Chang,

Journal of Hematology & Oncology

2019

48

Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era

Yu‐juan Xue, Yifei Cheng, Aidong Lu,

Biology of Blood and Marrow Transplantation

2018

40

Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapy

Guan-Hua Hu, Xiang‐Yu Zhao, Ying‐xi Zuo,

Leukemia

2021

33

Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment

Guanhua Hu, Yifei Cheng, Aidong Lu,

BMC Cancer

2020

32

Superior survival of unmanipulated haploidentical haematopoietic stem cell transplantation compared with intensive chemotherapy as post‐remission treatment for children with very high‐risk philadelphia chromosome negative B‐cell acute lymphoblastic leukaemia in first complete remission

Yu‐juan Xue, Pan Suo, Xiao‐Jun Huang,

British Journal of Haematology

2019

21

Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia

Lu Bai, Yifei Cheng, Aidong Lu,

Leukemia Research

2020

15

Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete Remission

Guanhua Hu, Yifei Cheng, Ying‐xi Zuo,

Frontiers in Immunology

2022

11

Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation Compared With Chemotherapy as Postremission Treatment of Children With Intermediate-risk Acute Myeloid Leukemia in First Complete Remission

Yu‐juan Xue, Yifei Cheng, Aidong Lu,

Clinical Lymphoma Myeloma & Leukemia

2020

10

Page 1